Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia. - Levis MJ; Hamadani M; Logan BR; Jones RJ; Singh AK; Litzow MR; Wingard JR; Papadopoulos EB; Perl AE; Soiffer RJ; Ustun C; Oshima MU; et al. (Blood advances, 2025)